Activation of mPTP-dependent mitochondrial apoptosis pathway by a novel pan HDAC inhibitor resminostat in hepatocellular carcinoma cells

Published 2016 View Full Article

Authors

Keywords

Hepatocellular carcinoma (HCC), HDAC inhibitor, Resminostat, mPTP, Mitochondrial apoptosis pathway, Sorafenib

Journal

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Volume 477, Issue 4, Pages 527-533

Publisher

Elsevier BV

Online

2016-05-02

DOI

10.1016/j.bbrc.2016.04.147

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started